Patient Monitoring Devices are used to observe, measure, and record vital signs in patients. A Bedside Multiparameter monitor is a combination of devices or processes that collects, transmits, and presents real-time health data for different parameters to professional health care providers. GlobalData uses proprietary data and analytics to provide a comprehensive report on the bedside multiparameter monitors devices market, including market shares of different players within New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the bedside multiparameter monitors market in New Zealand was Shenzhen Mindray Bio-Medical Electronics followed by GE HealthCare Technologies, Koninklijke Philips and Dragerwerk.
Vital data is captured through a set of capturing devices like ECG leads, pulse oximeters, inflatable rubber cuffs for blood pressure measurement etc., which is then electronically transmitted to a data collection device that consists of a software, which translates the binary information into health parameters which are displayed on a monitor. Some patient monitors are equipped with an alarm which is programmed to send an alert in case of an emergency, for example, if heart rate drops below or rises above a certain level.
The value of the bedside multiparameter monitors devices market within New Zealand was expected to be over $4m in 2023.
For the latest complete market share analysis of bedside multiparameter monitors device market in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
